Bikash Adhikari

Kiel, SH 24118, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications

On the Scope of DCAF1-Recruiting PROTACs Degrading Protein Kinases.

On the Scope of DCAF1-Recruiting PROTACs Degrading Protein Kinases.

Journal: Journal of medicinal chemistry
Published: June 17, 2026

Minute-scale control of ubiquitin-mediated degradation reveals dynamics of bacterial secreted effector-functions.

Minute-scale control of ubiquitin-mediated degradation reveals dynamics of bacterial secreted effector-functions.

Journal: Nature communications
Published: November 07, 2025

AURORA A interacts with DICER and SETD2 to promote S-phase progression.

AURORA A interacts with DICER and SETD2 to promote S-phase progression.

Journal: EMBO reports
Published: October 29, 2025

Targeted degradation of USP7 in solid cancer cells reveals distinct effects of deubiquitinase degraders and inhibitors.

Targeted degradation of USP7 in solid cancer cells reveals distinct effects of deubiquitinase degraders and inhibitors.

Journal: Nature communications
Published: July 03, 2025

Workflow for E3 Ligase Ligand Validation for PROTAC Development.

Workflow for E3 Ligase Ligand Validation for PROTAC Development.

Journal: ACS chemical biology
Published: February 11, 2025

Development and Discovery of a Selective Degrader of Casein Kinases 1 δ/ε.

Development and Discovery of a Selective Degrader of Casein Kinases 1 δ/ε.

Journal: Journal of medicinal chemistry
Published: December 27, 2024

Identification of suitable target/E3 ligase pairs for PROTAC development using a rapamycin-induced proximity assay (RiPA).

Identification of suitable target/E3 ligase pairs for PROTAC development using a rapamycin-induced proximity assay (RiPA).

Journal: eLife
Published: December 06, 2024

Development of 2-Aminoadenine-Based Proteolysis-Targeting Chimeras (PROTACs) as Novel Potent Degraders of Monopolar Spindle 1 and Aurora Kinases.

Development of 2-Aminoadenine-Based Proteolysis-Targeting Chimeras (PROTACs) as Novel Potent Degraders of Monopolar Spindle 1 and Aurora Kinases.

Journal: ACS pharmacology & translational science
Published: July 10, 2024

Combined targeted and epigenetic-based therapy enhances antitumor immunity by stabilizing GATA6-dependent MHCI expression in pancreatic ductal adenocarcinoma.

Combined targeted and epigenetic-based therapy enhances antitumor immunity by stabilizing GATA6-dependent MHCI expression in pancreatic ductal adenocarcinoma.

Journal: Nature communications
Published: June 09, 2024

Induced proximity to PML protects TDP-43 from aggregation via SUMO-ubiquitin networks.

Induced proximity to PML protects TDP-43 from aggregation via SUMO-ubiquitin networks.

Journal: Nature chemical biology
Published: February 20, 2024

Targeting MYC effector functions in pancreatic cancer by inhibiting the ATPase RUVBL1/2.

Targeting MYC effector functions in pancreatic cancer by inhibiting the ATPase RUVBL1/2.

Journal: Gut
Published: December 05, 2023

Generation of auxin inducible degron (AID) knock-in cell lines for targeted protein degradation in mammalian cells.

Generation of auxin inducible degron (AID) knock-in cell lines for targeted protein degradation in mammalian cells.

Journal: STAR protocols
Published: December 01, 2021
Showing 1-12 of 20

Last Updated: 09/26/2026